LINDE GAS NORTH AMERICA LLC
PharmaLINDE GAS NORTH AMERICA LLC is a pharmaceutical company with 1 FDA-approved products.
LINDE GAS NORTH AMERICA LLC's Key Drugs
LINDE GAS NORTH AMERICA LLC's core commercial portfolio centers on HELIUM, USP — its most strategically important drugs approved in the last 15 years.
LINDE GAS NORTH AMERICA LLC's Recent FDA Approvals
New NDA/BLA approvals for LINDE GAS NORTH AMERICA LLC over the last two years — novel drugs only, excluding generics and label supplements.
LINDE GAS NORTH AMERICA LLC's Therapeutic Areas
Disease areas where LINDE GAS NORTH AMERICA LLC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
LINDE GAS NORTH AMERICA LLC Pipeline Snapshot
Active clinical trials for LINDE GAS NORTH AMERICA LLC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • HELIUM, USP leads revenue
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2014-03-04
- Latest
- 2014-03-04
- Applications
- 1